Dow Up 0.08% Nasdaq Down 0.30%

OncoMed Pharmaceuticals, Inc. (OMED)

-NasdaqGS
17.16 Down 0.84(4.67%) Sep 19, 4:15PM EDT
|After Hours : 17.16 0.00 (0.00%) Sep 19, 4:40PM EDT
Prev Close:18.00
Open:18.23
Bid:17.17 x 100
Ask:N/A
1y Target Est:43.20
Beta:1.637
Next Earnings Date:N/A
Day's Range:17.04 - 18.53
52wk Range:12.07 - 42.34
Volume:299,712
Avg Vol (3m):210,729
Market Cap:510.68M
P/E (ttm):N/A
EPS (ttm):-1.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OMEDDown 4.67%510.68M
STMLDown 5.47%165.58M
VSTMDown 4.25%238.52M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.35
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem Cells (CSCs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback